- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hypersensitivity in South Africa
Total 745 results
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
GlaxoSmithKlineCompleted
-
Allergy TherapeuticsCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Global Alliance for TB Drug DevelopmentRecruitingDrug Sensitive Tuberculosis | Pulmonary Tuberculosis | Pulmonary TBPhilippines, South Africa, Tanzania, Georgia, Uganda
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Japan, Russian Federation, Bulgaria, Peru, Philippines, Poland, Mexico, Ukraine, Sweden, South Africa, Latvia, Puerto Rico, Georgia
-
SanofiRecruiting
-
GlaxoSmithKlineCompleted
-
Kinevant Sciences GmbHTerminatedSarcoidosis, CardiacUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthmaUnited States, Canada, Czechia, Hungary, Poland, Russian Federation, South Africa, Ukraine
-
University of AdelaideAustralasian Hyperbaric & Diving Medicine Research TrustCompletedOverweight and Obesity | Insulin SensitivityAustralia
-
Actavis Inc.Teva Pharmaceuticals USACompleted
-
GlaxoSmithKlineCompletedAsthmaCanada, Netherlands, United States, Sweden, Russian Federation
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Germany, Bulgaria, Canada, Chile, France, Peru, Russian Federation, South Africa, Mexico, Estonia, Netherlands, Thailand, Poland, Czechia
-
AstraZenecaCompletedAsthmaBrazil, France, South Africa, Spain, Vietnam, Germany, Philippines, Malaysia, China, Canada, Argentina, Australia, Mexico, Thailand, Indonesia, Singapore, India
-
Boehringer IngelheimCompletedAsthmaAustria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Russian Federation, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedRhinitis, Allergic, PerennialAustralia, Estonia, United States, Germany, Canada, New Zealand, Russian Federation, Lithuania, Latvia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Peru, Kenya, Puerto Rico
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited States, Canada, Spain, Netherlands, Germany, United Kingdom, Ireland, Sweden, France, Italy
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Canada, France, Germany, Netherlands, Poland, Mexico, United Kingdom, Czech Republic
-
AstraZenecaRecruitingAsthmaUnited States, Canada, South Africa, Korea, Republic of, Philippines, Czechia, Malaysia, Germany
-
SkyePharma AGCompleted
-
AstraZenecaNycomed GmbHCompletedAsthmaHungary, South Africa, Russian Federation, Spain, Poland, Germany, Bulgaria, Romania, Ukraine
-
AstraZenecaCompletedAsthma PatientsUnited States, Mexico, Russian Federation, South Africa, Romania, Ukraine, Japan, Argentina, Slovakia, Brazil
-
GlaxoSmithKlineCompletedRhinitis, Allergic, PerennialUnited States
-
AstraZenecaCompletedAsthmaHungary, South Africa, Germany, Brazil, India, Spain, Netherlands, Poland, Switzerland
-
Boehringer IngelheimCompleted
-
Pulmatrix Inc.TerminatedABPAAustralia, United States, United Kingdom, France
-
AstraZenecaCompletedAsthmaBulgaria, Czech Republic, Mexico, Poland, Russian Federation, South Africa, United Kingdom, Germany, Romania, Ukraine, Canada, Hungary, Slovakia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Japan, Chile, Peru, Philippines, Poland, Mexico, Slovakia, Ukraine, South Africa, Puerto Rico, Georgia
-
SunovionCompleted
-
AstraZenecaCompleted
-
AstraZenecaAmgenRecruitingAsthmaUnited States, Poland, Korea, Republic of, Spain, France, China, United Kingdom, Canada, Netherlands, Argentina, Mexico, Brazil, Hungary, Japan, Philippines, South Africa, Colombia
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingAsthmaUnited States, Japan, Poland, Spain, Italy, Australia, Taiwan, France, Hungary, Canada, Czechia
-
Hoffmann-La RocheCompletedAsthmaUnited States, South Africa, Russian Federation, Puerto Rico, New Zealand, Poland, Bulgaria, Romania, Brazil, Canada, United Kingdom, Czech Republic, Georgia, Slovakia
-
SanofiRecruitingDermatitis AtopicArgentina, Japan, China, Czechia, Spain, United States, South Africa, United Kingdom, Denmark, Sweden, Turkey
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Korea, Republic of, Poland, United Kingdom, Israel, Russian Federation, Italy, Turkey, Argentina, France, Hungary, Mexico, Canada, Czechia, Finland, Portugal, Romania, Slovakia, South Africa
-
Fougera Pharmaceuticals Inc.CompletedPsoriasis | Atopic DermatitisUnited States
-
AllerganCompletedAtopic ConjunctivitisCanada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
-
SanofiCompletedAsthmaUnited States, Brazil, Poland, Russian Federation, Estonia, Mexico, Israel, Chile, Latvia, Puerto Rico, Costa Rica
-
Boehringer IngelheimCompletedAsthmaUnited States, Australia, Canada, Colombia, Korea, Republic of, Mexico, New Zealand, Peru, Philippines, Taiwan
-
GlaxoSmithKlineCompletedAsthmaCanada, United States
-
SanofiActive, not recruitingDose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)AsthmaUnited States, Argentina, Brazil, Canada, Chile, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, South Africa, Turkey, United Kingdom
-
Escient Pharmaceuticals, IncRecruitingChronic Inducible UrticariaSpain, United States, Germany, Canada, Netherlands
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Hoffmann-La RocheCompletedAsthmaKorea, Republic of, United States, Belgium, Czechia, Germany, Peru, Bulgaria, Russian Federation, Argentina, Ukraine, Canada, Poland, South Africa, New Zealand, Romania